Sort by
Refine Your Search
-
Postdoctoral position: Developing a human lymphoid organ-on-chip to evaluate candidate mRNA vaccines
the formation of activated CD4+ T cell/B cell clusters, were recapitulated in the LO chip. Further, cells within the chip were competent at capturing and expressing mRNA vectored by lipid nanoparticles, enabling
-
understanding of how neural coding and speech perception are degraded in individuals with Auditory Neuropathy Spectrum Disorders (ANSD) [1]. The project leverages physiologically-informed computational models
-
A diverse postdoctoral community A dedicated career development support service within the institute A starting gross annual salary of €40,320, with raises based on years of experience after the PhD
-
, from new comprehensive community surveillance system RELAB, iv) studying and modelling the dynamics of antibodies following mosquito bites and exploring implications for the monitoring of mosquito born
-
with mouse models of infection will be appreciated. We are looking for strongly motivated and highly collaborative candidates having good communication skills in English and a sense of team spirit
-
hearing and deafness. Qualifications A PhD in molecular biology, genetics, epigenetics or related fields is required Two years of postdoctoral experience in these scientific fields is strongly preferred
-
with existing single-cell methods and software would represent a strong advantage. Excellent communication skills and team spirit, and an ability to work in autonomy are essential. Fluent English both
-
Send your CV along with a motivation letter to chloe.lehoucq@pasteur.fr with benjamin.devauchelle@pasteur.fr in Cc. The candidate should have a PhD in Neuroscience or Cognitive science and the
-
benjamin.devauchelle@pasteur.fr in Cc. The candidate should have a PhD in Human Genetics and the following skills: Strong interest in the field of genetics, neurobiology and psychiatry. Computer skills: strong level in
-
outline: Humoral immunity is fundamental to host defense against infectious agents and is driven by the extraordinary diversity of antibody molecules that detect and neutralize pathogens. Advances in single